3 reasons why I expect this FTSE 100 dividend stock to bounce back

Looking for undervalued FTSE 100 (INDEXFTSE: UKX) dividend shares? Rupert Hargreaves thinks you need look no further than this proven income hero.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in St. James’s Place (LSE: STJ) have plunged in value over the past three months, falling 17%, excluding dividends, compared to the FTSE 100’s decline of just 9%. 

And as the stock has dipped, St. James’s dividend yield has spiked. The shares now yield 5% and trade at a multiple of just 18 times 2019 earnings — below the five-year average of 33.

Here are three reasons why I believe this multiple is too low, and it’s only a matter of time before investors return to the business.

Market leader

St. James’s is, in my view, the UK’s leading wealth manager. Other companies out there, such as Nucleus Financial Group (LSE: NUC) have built a niche for themselves, but none are as established as St. James’s.

Nucleus is one of the company’s newest rivals. Technically, this business doesn’t manage money for clients. It provides a so-called ‘wrap’ platform for wealth managers to manage investments for their own clients. By aggregating all of the back office functions, Nucleus is using economies of scale to offer a better service for all stakeholders.

Steady growth

The second reason I believe it is only a matter of time before shares in St. James’s stage a rally, is the firm’s rate of growth. 

City analysts believe the group is on track to report earnings per share (EPS) growth of 63% for 2018, followed by an increase of 21% in 2019. However, recent numbers from the firm suggest that it may miss these lofty targets. A trading update earlier this week showed net inflows increased by 7% for the third quarter, a sharp slowdown from the 21% growth reported for the first half of 2018. 

Still, while the slowdown is disappointing, there’s no denying that St. James’s is heading in the right direction. What’s more, asset flows tend to be cyclical, so it’s more than likely that they will recover when the market’s performance improves.

Nucleus’ growth is on a similar trajectory. At the end of the third quarter, the company’s assets under administration (AUA) were £14.7bn, up 8.1% year-to-date, and up 14% over the previous year. That’s impressive growth considering the FTSE All Share Index has fallen 2.2% over the same period.

Meanwhile, the number of investment advisors actively using the platform has risen 7.2% over the past 12 months, and customer numbers have grown by 6.4%.

Modest valuation

My third and final reason why I believe St. James could outperform is the company’s valuation. 

As I mentioned above, the shares in the group are currently trading at a near 50% discount to its five-year average. If AUA growth starts to pick up again, and the company closes in on City growth targets, I reckon this discount will narrow over the medium term.

Shares in Nucleus, on the other hand, look relatively expensive. The company earned 5.4 p per share last year, and 2.8p per share for the first half of 2018 which, according to my calculations, puts the stock on a historical and forward P/E of 29.6 and 28.7, respectively. 

Even though the company might have a bright future, for me, this multiple leaves too much to chance and doesn’t give a margin of safety if growth stumbles, although it would appear management doesn’t seem to mind. Nucleus’ chairman and CTO have bought stock recently. Maybe they know something we don’t?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Growth Shares

Can the red hot Scottish Mortgage share price smash the FTSE 100 again in 2025?

The Scottish Mortgage share price moved substantially higher in 2024. Edward Sheldon expects further gains next year and in the…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant growth stocks to consider buying in 2025

Rising prices are back on the macroeconomic radar, meaning growth prospects are even more important for investors looking for stocks…

Read more »

Investing Articles

Why I’ll be avoiding BT shares like the plague in 2025

BT shares are currently around 23% below the average analyst price target for the stock. But Stephen Wright doesn’t see…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

5 Warren Buffett investing moves I’ll make in 2025

I’m planning to channel Warren Buffett in 2025. I won’t necessarily buy the same stocks as him, but I’ll track…

Read more »

Investing Articles

Here’s why 2025 could be make-or-break for this FTSE 100 stock

Diageo is renowned for having some of the strongest brands of any FTSE 100 company. But Stephen Wright thinks it’s…

Read more »

Investing Articles

1 massive Stocks and Shares ISA mistake to avoid in 2025!

Harvey Jones kept making the same investment mistake in 2024. Now he aims to put it right when buying companies…

Read more »

Value Shares

Can Lloyds shares double investors’ money in 2025?

Lloyds shares look dirt cheap today. But are they cheap enough to be able to double in price in 2025?…

Read more »

Investing Articles

How realistic is the 10%+ dividend yield from this FTSE 250 stock?

The FTSE 250 is brimming over with forecast dividend yields of 10% and even higher as we head into 2025.…

Read more »